[CDNA] CareDx, Inc.


Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization: 94.65 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 2.85 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CDNA

Refresh chart

Strongest Trends Summary For CDNA

CDNA is in the long-term up 1935% in 2 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient?s lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, Californ

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding18.93 M EPS-1.5 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.49% Sales Growth - Q/Q-9.26% P/E-0.73
P/E To EPS Growth P/S3.31 P/BV2.4 Price/Cash Per Share
Price/Free Cash Flow-23.18 ROA-0.3% ROE-0.47% ROI-0.34%
Current Ratio6.74 Quick Ratio6.62 Long Term Debt/Equity0.41 Debt Ratio0.16
Gross Margin68.21% Operating Margin0.3% Net Profit Margin-0.65% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.93 M Cash From Investing Activities-360 K Cash From Operating Activities-1.01 M Gross Profit4.5 M
Net Profit-2.27 M Operating Profit-1.39 M Total Assets63.28 M Total Current Assets42.3 M
Total Current Liabilities6.28 M Total Debt15.66 M Total Liabilities23.81 M Total Revenue7.22 M
Technical Data
High 52 week30.02 Low 52 week5.18 Last close29.51 Last change-0.3%
RSI59.78 Average true range1.54 Beta0.92 Volume12.77 K
Simple moving average 20 days12.37% Simple moving average 50 days16.33% Simple moving average 200 days39.41%
Performance Data
Performance Week11.32% Performance Month8.17% Performance Quart17.76% Performance Half46.23%
Performance Year464.25% Performance Year-to-date17.38% Volatility daily4.04% Volatility weekly9.03%
Volatility monthly18.5% Volatility yearly64.09% Relative Volume87.32% Average Volume689.5 K
New High New Low


2019-03-13 08:00:00 | Cedars Sinai Uses AlloSure in Tocilizumab Trial

2019-03-11 09:17:21 | These Factors Make CareDx, Inc NASDAQ:CDNA An Interesting Investment

2019-03-11 08:00:00 | AlloSure Heart Clinical Validation Published in Leading Transplant Journal

2019-03-10 08:00:51 | Cisco Leads 5 Top Stocks Flexing Strength With This Key Technical Indicator

2019-03-08 08:58:01 | CareDx CDNA in Focus: Stock Moves 9.8% Higher

2019-03-07 18:55:44 | Edited Transcript of CDNA earnings conference call or presentation 6-Mar-19 9:30pm GMT

2019-03-07 16:53:27 | Top-Rated Medical Stock Rockets After Turning A Profit A Quarter Early

2019-03-07 15:46:00 | Here's Why CareDX Is on the Move Today

2019-03-06 20:04:43 | CareDx Inc CDNA Q4 2018 Earnings Conference Call Transcript

2019-03-06 16:34:27 | This Highly Rated Medical Stock Just Turned Profitable A Quarter Early

2019-03-06 16:01:00 | CareDx Reports Fourth Quarter and FY 2018 Results

2019-03-05 08:00:00 | CareDx Welcomes Initiatives from US Government to Support Transplant Care

2019-02-26 08:00:00 | CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference

2019-02-21 08:00:00 | AlloSure now available for Lung Transplant Patients

2019-02-20 08:00:00 | CareDx Drives Personalized Medicine in Transplantation at CEOT

2019-02-19 07:45:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Sierra Wireless, United States Steel, CareDx, Cedar Fair, Unitil, and Cavco Industries — New Research Emphasizes Economic Growth

2019-02-14 08:00:00 | CareDx to Announce Fourth Quarter 2018 Financial Results on March 6th, 2019

2019-02-12 18:11:00 | This stock picker continues to outperform by using volatility as a ‘friend’

2019-02-07 11:08:22 | Read This Before Buying CareDx, Inc NASDAQ:CDNA Shares

2019-02-06 08:00:00 | CareDx to Participate in BTIG 6th Annual Medical Technology, Life Science Tools and Diagnostics Conference

2019-01-09 08:00:00 | CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium

2019-01-07 08:00:00 | CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results

2019-01-03 08:35:01 | CareDx Sees Hammer Chart Pattern: Time to Buy?

2019-01-02 11:10:04 | Best Sector of 2018 and its Hit ETFs & Stocks

2019-01-02 09:02:42 | Does The CareDx, Inc NASDAQ:CDNA Share Price Fall With The Market?

2018-12-20 07:00:00 | New Data on AlloSure Confirms Its Clinical Utility in Repeat Kidney Transplant Recipients

2018-12-18 16:11:48 | IBD Stock Of The Day Nears Profitability As Revenue Spikes

2018-12-17 16:01:00 | CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA

2018-12-17 01:36:33 | Do Hedge Funds Love CareDx, Inc. CDNA?

2018-11-28 08:25:00 | New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics — Factors of Influence, Major Initiatives and Sustained Production

2018-11-26 16:01:00 | CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer

2018-11-26 11:25:28 | What Kind Of Shareholder Appears On The CareDx Inc’s NASDAQ:CDNA Shareholder Register?

2018-11-26 08:00:00 | CareDx Announces Full Repayment of its Outstanding Debt

2018-11-16 16:01:00 | CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

2018-11-13 23:19:56 | CareDx Announces Pricing of Public Offering of Common Stock

2018-11-13 16:01:00 | CareDx Announces Proposed Public Offering of Common Stock

2018-11-08 21:35:54 | Edited Transcript of CDNA earnings conference call or presentation 8-Nov-18 9:30pm GMT

2018-11-08 18:20:11 | CareDx CDNA Reports Q3 Loss, Tops Revenue Estimates

2018-11-08 17:14:38 | CareDx: 3Q Earnings Snapshot

2018-11-08 16:01:00 | CareDx Reports Third Quarter Results

2018-11-07 08:00:00 | CareDx to Participate in Upcoming Investor Conferences

2018-11-01 14:46:00 | Harry Boxer’s four stocks to watch this week

2018-11-01 11:28:03 | CareDx CDNA May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2018-10-18 07:55:00 | Market Trends Toward New Normal in LSC Communications, Corindus Vascular Robotics, Sprouts Farmers Market, Luminex, ChromaDex, and CareDx — Emerging Consolidated Expectations, Analyst Ratings

2018-10-17 08:00:00 | CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018

2018-10-02 08:00:00 | CareDx Profiles AlloSeq Suite of NGS Products at ASHI

2018-09-21 08:00:00 | CareDx to Participate in Upcoming Investor Conference

2018-09-18 11:10:31 | CareDx Inc NASDAQ:CDNA: Are Analysts Optimistic?

2018-09-17 08:00:00 | CareDx broadens HeartCare availability

2018-09-07 15:57:45 | Stock Market Forecast: More Gains, More Volatility